1. FDA sees only slight dip in device approvals during pandemic — Novartis' Novartis to provide 'no profit' COVID drugs to low income countries — Relay Therapeutics prices IPO at $400M — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Zeltiq

Anonymous board for Zeltiq


Sort By:
Title
Replies Views
Last Message ↓
  1. Anonymous
    Replies:
    23
    Views:
    12,869
  2. anonymous
    Replies:
    3
    Views:
    7,164
  3. anonymous
    Replies:
    0
    Views:
    1,590
  4. anonymous
    Replies:
    7
    Views:
    3,951
  5. anonymous
    Replies:
    2
    Views:
    3,483
  6. anonymous
    Replies:
    6
    Views:
    3,781
  7. anonymous
    Replies:
    0
    Views:
    2,147
  8. anonymous
    Replies:
    1
    Views:
    2,481
  9. anonymous
    Replies:
    0
    Views:
    3,915
  10. Anonymous
    Replies:
    8
    Views:
    6,099
  11. anonymous
    Replies:
    0
    Views:
    2,065
  12. Anonymous
    Replies:
    1
    Views:
    3,397
  13. Anonymous
    Replies:
    2
    Views:
    3,897
  14. Anonymous
    Replies:
    3
    Views:
    4,672
  15. Anonymous
    Replies:
    4
    Views:
    6,237
  16. Anonymous
    Replies:
    2
    Views:
    3,469
  17. Anonymous
    Replies:
    8
    Views:
    9,915
  18. Anonymous
    Replies:
    2
    Views:
    4,774
  19. Anonymous
    Replies:
    0
    Views:
    3,104
  20. Anonymous
    Replies:
    0
    Views:
    4,178

Thread Display Options

Loading...